Dr. Comer is interested in the development of infectious disease models that can be used to evaluate the vaccine and therapeutics under the standards set by the United States Food and Drug Administration (FDA). Dr. Comer serves as a Study Director and plans and oversees preclinical studies to ensure they meet the FDA regulations. Dr. Comer has extensive experience designing and directing Good Laboratory Practice (GLP; 21 CFR Part 58)-compliant studies to test the efficacy of medical countermeasures to a variety of select agents. His end goal is to facilitate the FDA licensure of new vaccines and therapeutics to bio-threat agents and newly emerging diseases.
Publications/Creative Works
Click here to search for this faculty member's publications on PubMed.
Affiliations
Research Consortia
GCC Consortium for Antimicrobial Resistance (GCC AMR)
Important Disclaimer: The responsibility for the accuracy of the information contained on these pages lies with the authors and user providing such information.